NEW YORK (Reuters) – Groundbreaking treatments for Alzheimer’s disease that work by removing a toxic protein called beta amyloid from the brain may benefit whites more than Black Americans, whose disease may be driven by other factors, leading Alzheimer’s experts told Reuters. Read full story
Promising new Alzheimer's drugs may benefit whites more than Blacks
